Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Physiol., 29 January 2026

Sec. Exercise Physiology

Volume 17 - 2026 | https://doi.org/10.3389/fphys.2026.1727186

This article is part of the Research TopicMulti-omics insights into exercise-induced molecular adaptationsView all 3 articles

Aerobic exercise inhibits oxidative stress and improves diabetic cardiomyopathy in rats by activating the PROC/PAR1/Nrf2/HO-1 signaling pathway

Sicong Xie&#x;Sicong Xie1Cheng Chang&#x;Cheng Chang2Thi Mai TranThi Mai Tran1Zhiyi ZhouZhiyi Zhou1Chenshuo YuChenshuo Yu1Yucheng ChenYucheng Chen1Jiayin LinJiayin Lin1Jiaxuan XuJiaxuan Xu1Lei Wang
Lei Wang1*Yang Zhang
Yang Zhang1*
  • 1Department of Rehabilitation Medicine, School of Acupuncture-Moxibustion and Tuina and School of Health Preservation and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
  • 2Department of Cardiology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu, China

Diabetic cardiomyopathy (DCM) is a serious complication of end-stage diabetes that manifests as cardiac hypertrophy and heart failure. The present study performed a bioinformatics analysis to predict possible targets for aerobic exercise to improve DCM, and animal experiments were conducted to detect the relevant mechanisms. Oxidative stress (OS)-DCM-trained differentially expressed genes (DEGs) were retrieved from the GeneCards database and a Gene Expression Omnibus microarray dataset. Subsequently, a protein-protein interaction network was constructed to screen the hub genes of the OS-DCM-trained DEGs. In addition, a model of type 2 diabetes was established using streptozotocin and a high-fat diet. Rats were divided into the control, DCM and DCM plus exercise (DCME) groups. The DCME group underwent 8 weeks of moderate-intensity treadmill training. Assessment of cardiac function, myocardial enzymes and OS-related indicators in each group. Compared with the control group, the levels of BNP, CK-MB, c-TnT, LDH, MDA, LVEF, LVIDd, and LVIDs in the DCM group were significantly increased (P < 0.05), while SOD, GSH, and LVFS were significantly decreased (P < 0.05); The above indicators were significantly improved in DCME group rats (P < 0.05). In addition, the expression levels of target genes predicted to be associated with the aerobic exercise-induced improvement of DCM were detected and western blotting was used to determine the relevant signaling pathways. Bioinformatics analysis identified nine hub genes, which, according to Kyoto Encyclopedia of Genes and Genomes enrichment analysis, were mainly involved in “IL-17 signaling pathway,” “TNF signaling pathway,” “apoptosis” and “necroptosis.” Aerobic exercise improved the heart function and myocardial enzymes of the rats in the DCM group, reduced myocardial damage, and inhibited fibrosis and OS. Detection of the nine core genes revealed that only protein C (PROC) met the predicted trend; PROC expression was lower in the DCM group than that in the control group and was higher in the DCME group than that in the DCM group (P < 0.05). Further confirmation using western blotting suggested that aerobic exercise may improve DCM by activating the PROC/proteinase-activated receptor 1 (PAR1)/nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway. In conclusion, aerobic exercise may mitigate DCM by activating the PROC/PAR1/Nrf2/HO-1 signaling pathway. These findings could pave the way for further investigations into how exercise might regulate OS and influences DCM progression, providing novel insights into its diagnosis and prognosis.

1 Introduction

Type 2 diabetes has become increasingly common worldwide (Hu et al., 2013) and cardiovascular issues are the predominant causes of death among individuals with diabetes. Diabetic cardiomyopathy (DCM), a cardiac condition associated with diabetes, occurs independent of coronary artery disease and hypertension (Chavali et al., 2013). DCM is characterized by structural and functional anomalies of the heart, including myocardial hypertrophy, interstitial fibrosis, cardiomyocyte apoptosis, and impairments in diastolic and systolic functions (Huynh et al., 2014). These hallmarks of DCM contribute to the onset of heart failure and an elevated risk of mortality among affected individuals (Tribouilloy et al., 2008). Clinical studies have shown that early identification and diagnosis and timely treatment are crucial for controlling the patient’s condition (Chen et al., 2024).

DCM progression is also influenced by oxidative stress (OS) (Mohammed Yusof et al., 2018). Under physiological conditions, a number of cells continuously produce reactive oxygen species (ROS) such as superoxide radicals, hydroxyl radicals and hydrogen peroxide. ROS levels are regulated by several enzymes and physiological antioxidants including superoxide dismutase (SOD), glutathione (GSH) peroxidase, catalase and thioredoxin (Peng M. L. et al., 2022). However, excessive ROS production leads to OS, which negatively affects the functional integrity of biological tissues (Watanabe et al., 2010). Extensive experimental and clinical studies have shown that the production of ROS is increased in both types of diabetes, and that the onset of diabetes and its vascular complications, such as DCM, are associated with OS (Wu X. et al., 2022; Penckofer et al., 2002; Sano et al., 1998). Hyperglycemia, an important clinical manifestation of diabetes, is considered to produce ROS via the formation of advanced glycation end products (Mullarkey et al., 1990), altered polyol pathway activity (Williamson et al., 1993) and activation of NADPH oxidase via protein kinase C (Caturano et al., 2025).

Current studies on diabetic cardiomyopathy (DCM) have clearly established that oxidative stress is its core pathogenic mechanism: chronic hyperglycemia leads to excessive production of reactive oxygen species (ROS), which damages the myocardial antioxidant system and induces pathological abnormalities. Exercise can improve DCM by regulating oxidative stress through multiple pathways, such as reducing ROS production, upregulating the expression of superoxide dismutase (SOD), and activating the Keap1/Nrf2 pathway; among these, treadmill training not only enhances antioxidant capacity and reduces oxidative damage, but also alleviates DCM-related injury by reversing hyperacetylation of mitochondrial enzymes via the FGF21-SIRT3 axis (Liu et al., 2021). In addition, treadmill training can improve left ventricular systolic function (Libonati et al., 1985), an effect associated with the regulation of oxidative stress (OS) and enhancement of myocardial energy metabolism; this is because aerobic exercise can promote mitochondrial biogenesis, optimize calcium handling in cardiomyocytes, and reduce myocardial fibrosis, thereby providing support for the maintenance or restoration of left ventricular systolic function (Li et al., 2025; Pei et al., 2024; Zhang et al., 2024). However, studies on the targets related to the free radical scavenging system in treadmill training-mediated cardiac function protection in DCM remain scarce.

Genomics, transcriptomics, proteomics and metabolomics have generated notable amounts of data that can be analyzed by combining bioinformatics and computer science, resulting in new methods for studying the molecular mechanisms of diseases (Guo et al., 2022). Due to the rapid advancement of gene chip technology, the identification of differentially expressed genes (DEGs) and the examination of their roles have emerged as novel approaches for investigating the molecular underpinnings of disease progression (Cui et al., 2024). Notably, exercise causes systemic changes across physiology and molecular pathways hard to assess via one factor, but bioinformatics-based high-throughput technologies can detect and integrate multi-dimensional exercise-induced changes (e.g., gene expression, protein abundance, metabolites) missed by traditional single-target research, aiding in filtering core factors and clarifying key molecular drivers of exercise’s role in improving pathologies (Qi et al., 2024; Yan et al., 2017). The GSE129090 dataset was obtained in a study by Zhang et al. (2019a), which discovered that Bcl-2 was involved in the progression of cardiac hypertrophy. In addition, Grabowski et al. (2015) developed a rat model of left ventricular hypertrophy and investigated Efcab6 as a potential candidate for left ventricular hypertrophy.

Regarding protein C (PROC), a potential effector, previous studies have shown that its activated form, activated protein C (APC), can induce the expression of protective genes in endothelial cells by activating the endothelial protein C receptor (O'Brien et al., 2006) or protease-activated receptor 1 (PAR1) in the receptor cascade (Esmon, 2006; Liu et al., 2012) further confirmed that PAR1 can activate the nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway, thereby exerting an anti-oxidative stress effect. These studies suggest that PROC and its related signaling pathways hold significant research value for alleviating oxidative stress in DCM.

Based on the hypothesis that “aerobic exercise improves diabetic cardiomyopathy (DCM) by regulating core genes, activating signaling pathways and inhibiting oxidative stress (OS),” this study had two core objectives: first, to identify DCM-improving core genes related to aerobic exercise from multi-omics data via bioinformatics; second, to verify aerobic exercise’s therapeutic effect on DCM via animal experiments, detect the expression of selected core genes, explore underlying mechanisms, and provide potential molecular targets with hub genes as the key core for DCM intervention.

2 Materials and methods

2.1 Data source

GSE4616, GSE6880, GSE5606 and GSE4745 gene expression profiles were obtained from the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo), a repository of high-throughput gene expression data, hybridization arrays, chips and microarrays (Lehti et al., 2007; Van Lunteren and Moyer, 2007; Glyn-Jones et al., 2007; Gerber et al., 2006). GSE4616 is a dataset based on the GPL81 platform (Affymetrix Murine Genome U74A Version 2 Array) and includes nine mouse myocardial samples, three control samples (males), three DCM samples (males) and three DCM-trained samples (males). The DCM-trained group underwent 1 h of treadmill training daily at a speed of 21 m/min and an incline of 2.5°. Following 1 day of acclimatization training on the rodent treadmill, the mice underwent the aforementioned training regimen 5 days/week. GSE6880 is a dataset based on the GPL341 platform (Affymetrix Rat Expression 230A Array) and includes six rat myocardial samples, three control samples (males) and three DCM samples (males). GSE5606 is a dataset based on the GPL1355 platform (Affymetrix Rat Genome 230 2.0 Array) and includes 14 rat myocardial samples, seven control samples (males) and seven DCM samples (males). GSE4745 is a dataset based on the GPL85 platform (Affymetrix Rat Genome U34 Array) and includes 24 rat myocardial samples, 12 control samples (males) and 12 DCM samples (males).

The BioBase package 2.68 (https://bioconductor.org/packages/Biobase) was used to normalize the data. According to the annotation information on the platform, the probes were labeled with gene symbols, multiple probes corresponding to the same gene were randomly selected to remove duplicates and a gene expression matrix was obtained.

2.2 OS-related gene datasets

The GeneCards database (https://www.genecards.org/) (Xu et al., 2023) was searched using the term ‘oxidative stress’ as a screening condition to collect genes related to OS.

2.3 Data preprocessing and integration

The standardized expression matrix from the microarray data was obtained from the GEO datasets and depicted through a box-line plot created using the ‘ggplot2’ package (https://github.com/tidyverse/ggplot2) in R 4.2.1 (https://cran.r-project.org/bin/windows/base/old/4.2.1/). The probes were characterized using the annotation file of the dataset. Principal component analysis (PCA) was conducted to confirm the reproducibility and PCA visualizations were produced using the R package ‘ggplot2’.

The DEGs were screened using the “limma” package in R (https://bioinf.wehi.edu.au/limma/). The cutoff criteria for statistical significance were an absolute log2 fold change (logFC) > 1 and P < 0.05. A heat map and volcano plot of DEGs were constructed using the “ggplot” package.

2.4 Screening of DEGs and OS-DEGs between DCM and control samples

The “limma” package in R was used to screen for DEGs between DCM and control samples in the GSE4616, GSE6880, GSE5606 and GSE4745 datasets. P < 0.05 and |logFC|≥1 were set as the threshold values for DEG identification. Subsequently, OS-related genes were retrieved from the GeneCards database. The OS-related gene list intersected with the previously identified DEGs. The results obtained by the two methods were combined to screen OS-DEGs and their differential expression was analyzed, identifying upregulated and downregulated OS-DEGs.

2.5 Protein-protein interaction (PPI) network analysis

A PPI network was established using the Search Tool for the Retrieval of Interacting Genes (STRING) database (https://string-db.org), which encompassed the majority of functional interactions among the proteins encoded for by OS-DEGs. Interactions that achieved a combined score of >0.4 were considered statistically significant. The upregulated and downregulated OS-DEGs in the PPI network were examined using the STRING database.

2.6 Screening of DCM-trained DEGs and OS-DEGs

The “limma” package in R was used to screen for DEGs between DCM and DCM-trained samples in the GSE4616 dataset. P < 0.05 and |logFC|≥1 were set as the threshold values for DEG identification. Subsequently, lists of the aforementioned upregulated and downregulated OS-DEGs were generated, and these two lists were intersected with the DEGs between the DCM- and DCM-trained groups. The results obtained by the two methods were combined to screen OS-DCM-trained DEGs, and the differential expression of OS-DCM-trained DEGs was analyzed, identifying upregulated and downregulated OS-DCM-trained DEGs.

2.7 PPI network analysis of OS-DCM-trained DEGs

The PPI network was developed using the STRING database, which included nearly all functional interactions among proteins encoded by the OS-DCM-trained DEGs. Interactions with a combined score of >0.4 were regarded as statistically significant. Upregulated and downregulated OS-DCM-trained DEGs were examined using the STRING database.

2.8 Association analysis of OS-DCM-trained DEGs

The results of the OS-DCM-trained DEGs STRING analysis were visualized using Cytoscape (version 3.8.0) software (https://cytoscape.org/release_notes_3_8_0.html). The most closely connected modules from the PPI network (minimum required interaction score, 0.4) were selected for further analysis using the molecular complex detection plugin. The Cytoscape software plugin ‘cytoHubba’ (https://apps.cytoscape.org/apps/cytohubba) was used to filter hub genes from the entire PPI network, and to calculate the subgraph, information, local average connectivity, betweenness and closeness algorithms.

2.9 Gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) analyses

The Database for Annotation, Visualization, and Integrated Discovery (https://davidbioinformatics.nih.gov) (version 6.8) is a web-based analysis tool suite with an integrated discovery and annotation function that provides batch annotation and GO term enrichment analysis, in order to highlight the most relevant GO terms associated with related genes. The identified OS-DCM-trained DEGs were classified into three categories using GO analysis (ClusterProfiler package, https://www.bioconductor.org/packages/release/bioc/html/clusterProfiler.html): Molecular function (MF), biological process (BP) and cellular component (CC). Using Metascape (http://metascape.org), online KEGG enrichment analysis was also performed to predict the signaling pathways in which OS-DCM-trained DEGs may participate. Only terms with P < 0.05 were considered significant. The enriched pathways relevant to the current study are presented.

2.10 Experimental animals

Healthy 8-week-old male Sprague-Dawley rats (n = 15; weight, ∼200 ± 20 g; license SCXK 2019-0002; Hangzhou Medical College, Hangzhou, China) were housed at a constant temperature of 22 °C ± 2 °C and 40%–50% humidity, under a 12-h light/dark cycle. Rats were fed standard rodent mash for 1 week and water ad libitum, and were then randomly separated into two groups: Control (n = 5) and type 2 diabetes mellitus (D2M; n = 10). The control group was fed a normal diet, whereas the DCM group was fed a high-fat diet (HFD) (cat. no. D12492; Research Diets, Inc.). All animal procedures were performed in accordance with the institutional guidelines and approved by the Institutional Animal Care and Use Committee and the Ethics Committee for Science Research of the Nanjing University of Chinese Medicine (Nanjing, China; approval no. 202401A029).

2.11 Experimental protocol

The methodology for inducing type 2 diabetes in rats has been described previously (Peng M. L. et al., 2022). Following a 4-week period of a consistent HFD, rats in the DCM group underwent a 12-h fast. Subsequently, a 2% solution of streptozotocin (STZ; Beijing Solarbio Science & Technology Co., Ltd.), prepared in 0.01 mM citric acid buffer at pH 4.1, was administered intraperitoneally at a dosage of 30 mg/kg body weight. The control group received a single intraperitoneal injection of the same volume of 0.01 mM citric acid buffer. After a 72-h interval, 200 μL blood samples were randomly drawn from the tail vein for analysis. If blood glucose levels reached >11.1 mM, the DCM model was considered successfully established. A total of 10 rats were successfully modeled after 1 week of re-examination and removal of rats with substandard blood glucose. To measure blood glucose levels, ∼200 μL blood was collected from the tail vein of rats weekly for a total of 2 weeks, and tested using a blood glucose meter (Roche Diagnostics). The amount of blood collected was less than the recommended maximum weekly blood collection amount, which is 7.5% of the circulating blood volume. Rats with successful modeling were randomly divided into the DCM (n = 5) and DCM plus exercise (DCME; n = 5) groups.

Ten successfully modeled rats were grouped using a completely randomized design: first, the rats were numbered consecutively from 1 to 10, then 10 non-repetitive random numbers (ranging from 1 to 10) were generated by computer. After sorting the random numbers, the rats corresponding to numbers 1-5 were assigned to the DCM group (n = 5), and those corresponding to numbers 6-10 were assigned to the DCME group (n = 5). The grouping was performed by independent personnel to avoid bias.

The rats assigned to the DCME group underwent an initial week of adaptive training, which consisted of running at a speed of 10 m/min for 15 min daily. This was followed by an 8-week regimen of moderate-intensity aerobic treadmill exercise as previously described (Yang et al., 2024). The exercise parameters included a speed of 15.2 m/min and a slope of 3, corresponding to an exercise intensity of ∼58.40 ± 1.7% of VO2max. The sessions lasted 60 min per day and were conducted 5 days per week.

Studies have shown that 8 weeks of exercise training can achieve significant improvements in myocardial structure and function in diabetic cardiomyopathy (DCM) rats, providing sufficient time for the activation of relevant signaling pathways (Ma et al., 2025). Meanwhile, in rodent DCM models, moderate-intensity exercise has been widely confirmed to stably enhance myocardial antioxidant capacity (Wang and Feng, 2019). This intensity not only matches the clinically recommended exercise intensity for DCM patients but also avoids the risk of excessive cardiac load that may be induced by high-intensity exercise (Dias et al., 2018).

2.12 Insulin resistance test

Following a 12-h fasting period, serum samples were obtained from five rats each in the control group and the DCM group; briefly, 0.1 mL was collected from the tail vein of each rat, and centrifuged at 1,200 × g for 10 min at 2 °C–8 °C. The blood was allowed to clot for 30 min before serum collection. Fasting blood glucose (FBG) levels were measured using an automatic biochemical analyzer (Hitachi 7020; Hitachi, Ltd.) with a glucose oxidase kit (cat. no. ml059579; Shanghai Enzyme-linked Biotechnology Co., Ltd.). An enzyme-linked immunosorbent assay (ELISA) was used to measure fasting plasma insulin (FINS) (cat. no. HB549-Ra; Shanghai Hengyuan Biological Technology Co., Ltd.) using a microplate reader (WellScan MK3; LabSystems Diagnostics Oy). The insulin sensitivity index (ISI) and homeostatic model assessment of insulin resistance (HOMA-IR) were calculated using the following formulae: ISI = −log(FPG × FINS); HOMA-IR = (FPG × FINS)/22.5.

2.13 Echocardiogram

After 8 weeks of exercise, echocardiography was performed using a VINNO6 high-resolution imaging system [VINNO Technology (Suzhou) Co., Ltd.] following isoflurane anesthesia. The anesthesia protocol included induction with 4% isoflurane in 100% oxygen (1 L/min flow rate) using a precision evaporator and nasal cone, with anesthesia achieved within 2 min. Isoflurane concentration was maintained at 2% to ensure stable hemodynamics and to reduce cardiorespiratory depression. All procedures followed the institutional animal care guidelines and heating pads were used to maintain body temperature at 37 °C. Left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular internal diastolic dimension (LVIDd) and left ventricular internal dimension systole (LVIDs) were measured (Li et al., 2021).

2.14 Sample collection

After 8 weeks of exercise, all rats were euthanized. For euthanasia of Sprague-Dawley rats, sodium pentobarbital was administered intraperitoneally at a dose of 150 mg/kg. After sodium pentobarbital injection, death was confirmed by checking that rats were immobile, lacked a pain response when subjected to a toe pinch, were confirmed to lack a heartbeat and breathing, and exhibited dilated pupils. This protocol ensured rapid and humane euthanasia while complying with American Veterinary Medical Association guidelines (Gu et al., 2016).

In addition, for blood collection, pentobarbital sodium (50 mg/kg rat body weight; 1% solution concentration) was administered intraperitoneally to all rats in each group and the disappearance of corneal reflexes and stabilization of thoracic respiration were observed (Clifford et al., 2018). Subsequently, ∼10 mL blood was obtained from the abdominal aorta from rats weighing 250 g, and the rats were immediately euthanized upon completion of this procedure, by sodium pentobarbital overdose. These blood samples were then centrifuged at 1,200 × g for 15 min at 25 °C before the supernatant was collected. Upon collection of blood samples, the hearts of the rats were excised and rinsed with cold 0.9% saline. The surrounding vessels and connective tissues, along with the atrial and right ventricular tissues, were carefully removed. The procured cardiac tissue was then divided into two portions: Apical sections were swiftly frozen in liquid nitrogen (−196 °C) for subsequent western blot analysis and the remaining tissue was preserved in 10% neutral-buffered formalin for fixation at room temperature for 4 h.

2.15 Histological evaluation

The excised heart tissues were embedded in paraffin and the tissue samples were sliced into 5-μm sections for later staining with hematoxylin and eosin (H&E) at 90 °C for 30 min. Masson’s trichrome staining was also performed on the 5-μm sections to assess interstitial fibrosis (Zhang et al., 2019b). Images were obtained using a light microscope (BX51; Olympus Corporation) and a digital imaging system (DP71; Olympus Corporation). H&E- and Masson’s trichrome-stained tissue sections were examined at ×200 magnification.

2.16 Assessment of biochemical parameters

Serum levels of brain natriuretic peptide (BNP; cat. no. SEKR-0058; Beijing Solarbio Science & Technology Co., Ltd.), creatine kinase MB (CK-MB; cat. no. SEKR-0059; Beijing Solarbio Science & Technology Co., Ltd.), cardiac troponin T (c-TnT; cat. no. SEKR-0047; Beijing Solarbio Science & Technology Co., Ltd.), malondialdehyde (MDA; cat. no. SP30131; Wuhan Saipei Biotechnology Co., Ltd.), lactate dehydrogenase (LDH; cat. no. ml106660; Shanghai Enzyme-linked Biotechnology Co., Ltd.), GSH (cat. no. SP12673; Wuhan Saipei Biotechnology Co., Ltd.) and SOD (cat, no. SP12914; Wuhan Saipei Biotechnology Co., Ltd) were measured using ELISA kits, according to the manufacturer’s instructions.

2.17 Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Total RNA was extracted from the myocardium using an RNA extraction kit (cat. no. R1051; Guangzhou Dongsheng Biotech Co., Ltd.), and was used to synthesize cDNA using All-in-One first-strand cDNA Synthesis SuperMix for qPCR (TransGen Biotech Co. Ltd.) according to the manufacturer’s protocol. A Tip Green qPCR SuperMix kit (TransGen Biotech Co., Ltd.) was used for qPCR according to the manufacturer’s instructions, with GAPDH used as the housekeeping gene. The thermocycling conditions were as follows: Pre-denaturation at 95 °C for 3 min, followed by 40 cycles of denaturation at 95 °C for 10 s followed by annealing/extension at 60 °C for 30 s. The mRNA expression levels of the target genes (Table 1) were calculated using the 2−ΔΔCq method.

Table 1
www.frontiersin.org

Table 1. Primer sequences for reverse transcription-quantitative PCR.

2.18 Concentrations of activated protein C (APC)

The concentration of APC in the tissue homogenate samples was determined using a commercially available Rat APC ELISA Kit (cat. no. XYR121; XYbio) according to the manufacturer’s instructions. Before the test, the frozen serum samples were thawed and centrifuged again at 1,000 × g for 15 min at 4 °C and all reagents in the ELISA kit were brought to room temperature. The serum supernatant was added and the test performed according to the manufacturer’s instructions.

2.19 Western blot analysis

Western blot analysis was used to determine the protein levels in rat myocardial tissue samples. Briefly, mouse myocardial tissue samples were rapidly homogenized in 200 μL RIPA lysis buffer (cat. no. P0013C; Beyotime Institute of Biotechnology) and protein levels were determined using the BCA method. Subsequently, 20 μg protein/lane were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 10% gel, and the proteins were then transferred onto nitrocellulose membranes. The membranes were blocked with 5% non-fat dry milk in Tris-buffered saline for 60 min at room temperature and then incubated with anti-PROC (1:1,000; cat. no. MA5-35528; Thermo Fisher Scientific, Inc.), anti-tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD) (1:500) (cat. no. 703356; Thermo Fisher Scientific, Inc.), anti-caspase-8 (CASP8) (1:1,000; cat. no. MA1-41280; Thermo Fisher Scientific, Inc.), anti-cleaved CASP8 (1:1,000; cat. no. PA5-99435; Thermo Fisher Scientific, Inc.), anti-proteinase-activated receptor 1 (PAR1) (1:1,000; cat. no. PA5-116040; Thermo Fisher Scientific, Inc.), anti-nuclear factor (erythroid-derived 2)-like 2 (Nrf2; 1:1,000; cat. no. PA5-27882; Thermo Fisher Scientific, Inc.), anti-heme oxygenase-1 (HO-1; 1:1,000; cat. no. PA5-77833; Thermo Fisher Scientific, Inc.) and anti-GAPDH (1:1,000; cat. no. MA5-35235; Thermo Fisher Scientific, Inc.) antibodies. The membranes were incubated overnight at 4 °C and washed three times before being incubated with the appropriate HRP-conjugated anti-rabbit (1:5,000; cat. no. 32460; Thermo Fisher Scientific, Inc.) or anti-mouse secondary antibodies (1:5,000; cat. no. 31431; Thermo Fisher Scientific, Inc.) for 60 min at room temperature. Enhanced chemiluminescent reagents (cat. no. 34098CN; Thermo Fisher Scientific, Inc.) were used to visualize protein bands. A digital gel imaging system was used to examine the protein expression levels (Alpha Imager2200 3.2; ProteinSimple).

2.20 Statistical analysis

All data are expressed as mean ± SD and were analyzed using SPSS 21.0 (IBM, United States). Normality and homoscedasticity were assessed using the Shapiro-Wilk test and Levene’s test, respectively. For data meeting the assumptions of normality and equal variance, an unpaired Student’s t-test was employed for two-group comparisons, and one-way ANOVA followed by Tukey’s post-hoc test was used for multiple group comparisons. A value of P < 0.05 was considered statistically significant.

3 Results

3.1 Screening of OS-DEGs between DCM and control groups

Four datasets were chosen to examine variations in gene expression between the DCM and control groups. The expression matrices for the GSE4616, GSE6880, GSE5606 and GSE4745 datasets were normalized, resulting in box plots that displayed the distribution trends as straight lines (Figures 1A–D). PCA was conducted on the four datasets to evaluate the consistency of the data within each group. The results indicated a high level of repeatability (Figures 1E–H). Figures 1I–L shows the partial gene heat maps of the four datasets.

Figure 1
Graphs and heatmaps displaying gene expression data across four datasets (GSE4745, GSE5606, GSE6880, GSE4616). Panels A-D show box plots of normalized signal intensity, Panels E-H depict PCA plots differentiating control and DCM groups, and Panels I-L feature heatmaps visualizing gene expression patterns, with blue representing control and red representing DCM.

Figure 1. Differentially expressed genes in control and DCM samples. Normalized expression matrices for (A) GSE4745, (B) GSE5606, (C) GSE6880 and (D) GSE4616. Principal component analysis diagrams of the (E) GSE4745, (F) GSE5606, (G) GSE6880 and (H) GSE4616 datasets. Part of the hierarchical clustering heat maps of the (I) GSE4745, (J) GSE5606, (K) GSE6880 and (L) GSE4616 datasets showing the differentially expressed genes in the control and DCM samples. DCM, diabetic cardiomyopathy.

After screening with the threshold of an adjusted |logFC| > 1 and P < 0.05, 105 DEGs (58 upregulated and 47 downregulated in the DCM group) were identified in the GSE4745 dataset (Supplementary Table S1), 90 DEGs (45 upregulated and 45 downregulated in the DCM group) in the GSE5606 dataset (Supplementary Table S2), 382 DEGs (198 upregulated and 184 downregulated in the DCM group) in the GSE6880 dataset (Supplementary Table S3) and 238 DEGs (111 upregulated and 127 downregulated in the DCM group) in the GSE4616 dataset (Supplementary Table S4). Volcano plots of the DEGs in the four datasets are shown in Figures 2A–D. A total of 370 upregulated and 371 downregulated genes were identified by merging the upregulated and downregulated genes from the four datasets. The GeneCards database was used to cross-reference genes encoding OS proteins with the DEGs. A total of 13,196 related genes were identified in the GeneCards database (Supplementary Table S5), and 224 upregulated and 229 downregulated OS-DEGs were identified (Figures 2E,F). A PPI network was created by determining the interactions between upregulated and downregulated OS-DEGs. The PPI network showed that most OS-DEGs interacted with each other, and that the closer they were to the center of the network, the more genes they interacted with Figures 2G,H.

Figure 2
Graphs A to D display volcano plots for datasets GSE4745, GSE6506, GSE6880, and GSE4616, showing log2 fold change against negative log p-values. Plots E and F are Venn diagrams demonstrating overlaps between upregulated or downregulated differentially expressed genes (DEGs) and oxidative stress genes. Plots G and H feature network diagrams indicating gene interaction networks, with various nodes and connections illustrated.

Figure 2. DEGs and OS-related genes of the GSE4745, GSE5606, GSE6880 and GSE4616 datasets. (A–D) Volcano plots of DEGs. The red nodes represent upregulated DCM-related DEGs with P < 0.05 and logFC>1; the blue nodes represent downregulated DCM-related DEGs with P < 0.05 and logFC<-1. (E,F) Venn diagrams of 224 upregulated OS-DEGs and 229 downregulated OS-DEG. (G,H) Protein-protein interaction network diagrams of OS-DEGs. Not sig, not significant; DEGs, differentially-expressed genes; OS, oxidative stress.

3.2 Screening of OS-DCM-trained DEGs

The GSE4616 dataset was the only one assessed in the present study that used aerobic exercise intervention on DCM. The expression matrices within the GSE4616 dataset were normalized, resulting in box plots that exhibited linear distribution trends (Figure 3A). To evaluate intragroup data reproducibility, PCA was conducted on the dataset, which revealed a high degree of repeatability (Figure 3B). Figure 3C shows a partial heat map of the dataset.

Figure 3
A composite of several data visualizations analyzing gene expression. Panel A shows a box plot of normalized signal intensity for two groups, DCM and DCM trained. Panel B is a PCA plot distinguishing the groups. Panel C is a heatmap of gene expression. Panels D and E display Venn diagrams showing overlaps in upregulated and downregulated differentially expressed genes. Panel F is a volcano plot highlighting significant gene expression changes. Panel G and H show protein interaction networks. Panel I lists top genes based on different centrality measures.

Figure 3. DEGs in DCM and DCM-trained samples. (A) Normalized expression matrices of the GSE4616 dataset. (B) Principal component analysis diagrams of the GSE4616 dataset. (C) Part of the hierarchical clustering heat map of the GSE4616 dataset DEGs in DCM and DCM-trained samples. Venn diagrams of (D) seven upregulated OS-DCM-trained DEGs and (E) 19 downregulated OS-DCM-trained DEGs. (F) Volcano plot of seven upregulated OS-DCM-trained DEGs and 19 downregulated OS-DCM-trained DEGs. (G,H) Protein-protein interaction network diagrams of OS-DCM-trained DEGs. (I) Nine hub genes of upregulated OS-DCM-trained DEGs using Cytoscape. DCM, diabetic cardiomyopathy; DEGs, differentially-expressed genes; FGG, fibrinogen γ chain; HGD, homogentisate 1,2-dioxygenase; PROC, protein C; TRADD, tumor necrosis factor receptor type 1-associated DEATH domain protein; GC, vitamin D-binding protein; CCNA1, cyclin A1; SPAG5, sperm-associated antigen 5; CASP8, caspase-8; TOP2A, DNA topoisomerase 2α; Not sig, not significant; LAC, local average connectivity.

After screening using the thresholds of adjusted |logFC| > 1 and P < 0.05, 204 DCM-trained DEGs (117 upregulated and 87 downregulated) were identified in the GSE4616 dataset (Supplementary Table S6). Subsequently, using a Venn diagram, the upregulated OS-DEGs were intersected with the downregulated DCM-trained DEGs, resulting in seven DEGs (Figure 3D). Simultaneously, 19 DEGs were identified by intersecting the downregulated OS-DEGs with the upregulated DCM-trained DEGs (Figure 3E). A volcano plot illustrating the DEGs identified by OS-DCM training in the aforementioned datasets is shown in Figure 3F. The PPI network was created by determining the interactions between the downregulated (Figure 3G) and upregulated OS-DCM-trained DEGs (Figure 3H).

3.3 Identification of hub genes

The PPI results showed no association between the downregulated OS-DCM-trained DEGs (Figure 3G). Therefore, further research did not focus on these genes and instead investigated the upregulated OS-DCM-trained DEGs. The STRING analysis data were imported into Cytoscape and genes with scores were designated as hub genes. The top hub genes were identified using four different algorithms. An upshot diagram of the results of these algorithms revealed nine common hub genes: Fibrinogen γ chain (FGG), homogentisate 1,2-dioxygenase (HGD), PROC, TRADD, vitamin D-binding protein (GC), cyclin A1 (CCNA1), sperm-associated antigen 5 (SPAG5), CASP8 and DNA topoisomerase 2α (TOP2A) (Figure 3I).

3.4 GO and KEGG analyses

GO and KEGG enrichment analyses of the upregulated OS-DCM-trained DEG hub genes were used to investigate their functions (Figures 4A,B). The ClusterProfiler package (https://www.bioconductor.org/packages/release/bioc/html/clusterProfiler.html) enriched GO function was used to determine the BP, CC and MF terms the hub genes were enriched in. The most enriched GO categories included “extrinsic apoptotic signaling pathway via death domain receptors,” “extrinsic apoptotic signaling pathway,” “cysteine-type endopeptidase activity involved in apoptotic signaling pathway,” “oxidoreductase activity, acting on single donors with incorporation of molecular oxygen” and “oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen.” Hub genes were mainly involved in apoptotic processes, such as “IL-17 signaling pathway,” “TNF signaling pathway,” “apoptosis” and “necroptosis” in the KEGG enrichment analysis.

Figure 4
Circular diagram labeled A, showing gene interactions with color-coded log fold change, connected to various Gene Ontology (GO) terms. Accompanying table labeled B lists ontology categories, GO IDs, descriptions, gene ratios, background ratios, p-values, adjusted p-values, and z-scores. The table includes biological processes, cellular components, molecular functions, and KEGG pathways related to apoptosis and signaling.

Figure 4. GO and KEGG analyses. (A,B) GO and KEGG pathway enrichment analyses. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; logFC, log2 fold change; BP, biological process; MF, molecular function; CC, cellular component; FGG, fibrinogen γ chain; HGD, homogentisate 1,2-dioxygenase; PROC, protein C; TRADD, tumor necrosis factor receptor type 1-associated DEATH domain protein; GC, vitamin D-binding protein; SPAG5, sperm-associated antigen 5; CASP8, caspase-8; TOP2A, DNA topoisomerase 2α.

3.5 Effects of aerobic exercise on body weight and blood glucose in diabetic rats

As shown in Figures 5A–D, rats in the DCM group exhibited significantly elevated FBG and FINS levels compared with those in the control group (both P < 0.05), along with significantly reduced ISI (P < 0.05) and increased HOMA-IR (P < 0.05). These findings suggested heightened insulin resistance in the DCM group, demonstrating that the current animal model aligned with the characteristics of type 2 diabetes.

Figure 5
Bar graphs labeled A to F compare various metrics between control (CON), diabetic cardiomyopathy (DCM), and DCME groups. Graph A shows fasting blood glucose is higher in DCM. Graph B shows fasting insulin is higher in DCM. Graph C shows insulin sensitivity index is lower in DCM. Graph D shows HOMA-IR is higher in DCM. Graph E shows body weight is lower in DCM and DCME. Graph F shows blood glucose is higher in DCM and DCME. An asterisk denotes significant difference.

Figure 5. Changes in insulin sensitivity, body weight and blood glucose of rats with DCM. (A) FBG levels. (B) FINS levels. (C) ISI. (D) HOMA-IR. (E) Changes in rat body weight. (F) Changes in FBG. Data are presented as the mean ± SD (n = 5). *P < 0.05 vs. CON group. DCM, diabetic cardiomyopathy; FBG, fasting blood glucose; FINS, fasting plasma insulin; ISI, insulin sensitivity index; HOMA-IR, homeostatic model assessment of insulin resistance; CON, control; DCME, DCM plus exercise.

Changes in the body weight of the rats are shown in Figure 5E. Compared with in the control group, the weights of rats in the DCM and DCME groups were significantly reduced (P < 0.05). Rats in the DCME group were heavier than those in the DCM group; however, the difference was not statistically significant. Figure 5F shows changes in blood glucose levels. Compared with those in the DCM group, blood glucose levels were not significantly different in the DCME group (P > 0.05).

3.6 Effects of aerobic exercise on serum myocardial enzymes levels

As shown in Figures 6A–D, the serum levels of LDH, CK-MB, c-TnT and BNP were significantly elevated in the DCM group compared with those in the control group (P < 0.05). However, exercise training in the DCME group led to a significant reduction in LDH, CK-MB, c-TnT and BNP levels compared with those in the DCM group (P < 0.05).

Figure 6
Bar charts labeled A to G compare biomarker levels between three groups: CON, DCM, and DCME. Each chart represents different biomarkers: A for BNP, B for CK-MB, C for c-TnT, D for LDH, E for MDA, F for GSH, and G for SOD. Notably, DCM and DCME groups show elevated levels compared to CON in most charts, with DCME often showing reductions compared to DCM. Asterisks represent statistical significance.

Figure 6. Effects of aerobic exercise on myocardial enzymes and oxidative stress indexes in rats with DCM. Representative (A) BNP, (B) CK-MB, (C) c-TnT and (D) LDH levels. (E) MDA content. (F) GSH and (G) SOD levels. Data are presented as the mean ± SD (n = 5). *P < 0.05 vs. CON group; #P < 0.05 vs. DCM group. BNP, brain natriuretic peptide; CK-MB, creatine kinase MB; c-TnT, cardiac troponin T; LDH, lactate dehydrogenase; MDA, malondialdehyde; GSH, glutathione; SOD, superoxide dismutase; CON, control; DCM, diabetic cardiomyopathy; DCME, DCM plus exercise.

3.7 Effects of aerobic exercise on myocardial OS in diabetic rats

Compared with that in the control group, the MDA content in the DCM group was significantly increased (P < 0.05), and the MDA content in the DCME group was significantly lower than that in the DCM group (P < 0.05), but was still significantly higher than that in the control group (P < 0.05) (Figure 6E). Furthermore, compared with those in the control group, the activities of SOD and GSH were significantly reduced in the DCM group (P < 0.05); however, compared with those in the DCM group, the SOD and GSH activities were significantly higher in the DCME group (P < 0.05) but remained significantly lower than those in the control group (P < 0.05) (Figures 6F,G).

3.8 Effects of aerobic exercise on myocardial pathological abnormalities

After H&E staining (Figure 7A), myocardial cells in the control group appeared to be compact and arranged in an orderly manner, with bright red cytoplasm and centrally located oval nuclei. No dissolved muscle fibers, vacuolar degeneration or mononuclear cell infiltration were observed. However, in the DCM group, myocardial cells were disordered, and uneven cytoplasmic distribution, ruptured myocardial fibers and irregular nuclei were observed. The DCME group demonstrated reduced myocardial injury following moderate-intensity exercise training. Masson’s trichrome staining (Figure 7B) revealed well-organized collagen fibers and no notable myocardial interstitial collagen deposition in the control group. By contrast, the DCM group displayed disorganized myocardial cells and a marked increase in interstitial collagen fibers within both intercellular and perivascular spaces. The DCME group showed reduced collagen fiber content compared with in the DCM group.

Figure 7
Histological and echocardiographic analysis of heart tissue. Panel A shows H&E staining; CON appears normal, while DCM and DCME show fibrotic changes. Panel B illustrates Masson's trichrome staining indicating fibrosis. Panel C displays echocardiography images. Panel D presents bar graphs comparing LVEF, LVFS, LVIDd, and LVIDs across CON, DCM, and DCME groups, showing differences in cardiac function measures. Scale bars are 10 micrometers for histology.

Figure 7. Effects of exercise training on histopathological and echocardiographic abnormalities in myocardial tissue. (A) H&E staining (×200 magnification) showed irregular arrangement of myocardial cells, uneven distribution of cytoplasm and ruptured myocardial fibers in the DCM group, whereas exercise training attenuated these histopathological changes. (B) Masson’s trichrome staining (×200 magnification) showed irregular and noticeably increased interstitial collagen fibers (blue region) in the DCM group. (C) Echocardiography of rats in each group. (D) LVEF, LVFS, LVIDd and LVIDs in each group of rats. Data are presented as the mean ± SD (n = 3). *P < 0.05 vs. CON group; #P < 0.05 vs. DCM group. H&E, hematoxylin and eosin; CON, control; DCM, diabetic cardiomyopathy; DCME, DCM plus exercise; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVIDd, left ventricular diastolic dimension; LVIDs, left ventricular systolic dimension.

3.9 Effect of aerobic exercise on echocardiography

Compared with those in the control group, the LVEF and LVFS of the DCM group were significantly decreased, but the LVIDd and LVIDs were significantly increased, indicating impaired cardiac contractile function in the DCM group (Figures 7C,D). In addition, compared with those in the DCM group, the DCME group had significantly increased LVEF and LVFS, and decreased LVIDd and LVIDs, thus indicating improved cardiac contractile function (Cheng et al., 2022; Wu et al., 2024).

3.10 RT-qPCR detection of the expression of hub genes in heart tissues

RT-qPCR was used to examine the expression levels of FGG, HGD, PROC, TRADD, GC, CCNA1, SPAG5, CASP8 and TOP2A in different samples (Figures 8A–I). According to bioinformatics predictions, compared with those in the control group, the target genes in the DCM group would be significantly reduced. By contrast, compared with in the DCM group, the target genes in the DCME group rats would be significantly elevated. Only PROC, TRADD and CASP8 conformed to the predicted patterns.

Figure 8
Bar graphs A-I show relative mRNA expression levels for genes FGG, HGD, PROC, TRADD, CASP8, CCNA1, SPAG5, GC, and TOP2A across three groups: CON, DCM, and DCME. Genes TRADD, CASP8, and PROC show significant differences marked by asterisks and hash signs.

Figure 8. Effect of aerobic exercise on the expression levels of predicted genes in rats with DCM. Representative (A) FGG, (B) HGD, (C) PROC, (D) TRADD, (E) CASP8, (F) CCNA1, (G) SPAG5, (H) GC and (I) TOP2A mRNA expression levels. Data are presented as the mean ± SD (n = 3). *P < 0.05 vs. CON group; #P < 0.05 vs. DCM group. CON, control; DCM, diabetic cardiomyopathy; DCME, DCM plus exercise; FGG, fibrinogen γ chain; HGD, homogentisate 1,2-dioxygenase; PROC, protein C; TRADD, tumor necrosis factor receptor type 1-associated DEATH domain protein; GC, vitamin D-binding protein; CCNA1, cyclin A1; SPAG5, sperm-associated antigen 5; CASP8, caspase-8; TOP2A, DNA topoisomerase 2α.

3.11 Western blot detection of the expression of hub genes in heart tissues

Compared with that in the control group, the DCM group showed a significant decrease in PROC expression in cardiac tissues (Figures 9A,D). By contrast, compared with in the DCM group, the DCME group showed a significant increase in PROC. Compared with in the control group, TRADD expression was significantly elevated in cardiac tissue from the DCM group (Figures 9A,B). Conversely, TRADD expression was markedly reduced in the DCME group relative to the DCM group. Compared with in the control group, CASP8 expression was significantly increased in cardiac tissue from the DCM group; CASP8 expression was further increased in the DCME group relative to the DCM group (Figures 9A,C). Compared with in the control group, the cleaved-CASP8/CASP8 ratio was significantly increased in cardiac tissue from the DCM group, whereas it was decreased in the DCME group relative to the DCM group (Figures 9A,E).

Figure 9
Western blot analysis and bar graphs showing protein expression levels under different conditions labeled CON, DCM, and DCME. Panel A displays bands for TRADD, CASP8, cleaved-CASP8, PROC, and GAPDH. Panels B to J show relative expression levels and concentration differences for TRADD, CASP8, PROC, cleaved-CASP8/CASP8 ratio, and active PROC, as well as bands for PAR1, Nrf2, HO-1, and GAPDH. Statistically significant differences are marked with asterisks and hashes.

Figure 9. Effect of aerobic exercise on the expression levels of predicted proteins and of proteins in the PROC/PAR1/Nrf2/HO-1 signaling pathway in rats with DCM. (A) Representative TRADD, cleaved-CASP8, CASP8 and PROC levels; GAPDH was used as an internal control. (B–E) Representative TRADD and PROC ratios to GAPDH protein, and cleaved-CASP8/CASP8 ratio. (F) Representative active PROC levels. (G) Representative PAR1, Nrf2 and HO-1 levels; GAPDH was used as an internal control. (H–J) Representative PAR1, Nrf2 and HO-1 to GAPDH protein ratios. Data are presented as the mean ± SD (n = 3). *P < 0.05 vs. CON group; #P < 0.05 vs. DCM group. PROC, protein C; PAR1, proteinase-activated receptor 1; Nrf2, nuclear factor (erythroid-derived 2)-like 2; HO-1, heme oxygenase-1; TRADD, tumor necrosis factor receptor type 1-associated DEATH domain protein; CASP8, caspase-8; CON, control, DCM, diabetic cardiomyopathy; DCME, DCM plus exercise.

3.12 Concentrations of serum APC

As shown in Figure 9F, compared with that in the control group, the APC content in the DCM group was significantly lower than that in the control group (P < 0.05), whereas the APC content in the DCME group was significantly higher than that in the DCM group (P < 0.05).

3.13 Western blot detection of the expression of PROC/PAR1/Nrf2/HO-1 signaling pathway proteins in heart tissues

As shown in Figures 9G–J, compared with those in the control group, the protein levels of Nrf2 and HO-1 were significantly reduced in the DCM group (P < 0.05), whereas the levels of PAR1, Nrf2 and HO-1 were significantly increased in the DCME group compared with those in the DCM group (P < 0.05).

4 Discussion

In this study, differentially expressed genes related to OS and DCM were screened from 4 GEO datasets. A PPI network was constructed, leading to the identification of 9 hub genes (e.g., PROC). Animal experiments confirmed that 8 weeks of aerobic exercise improved cardiac function, alleviated injury and OS in DCM rats, and only the expression of PROC was consistent with the prediction. Finally, it was verified that aerobic exercise exerts its effect by activating the PROC/PAR1/Nrf2/HO-1 pathway. This study is the first to identify PROC as a key node in aerobic exercise-regulated DCM, filling the gap in genetic targets and providing a new direction for DCM intervention.

DCM is the leading cause of mortality in patients with diabetes, and no specific treatment is currently available in clinical practice (Livak and Schmittgen, 2001; Palomer et al., 2018). Regular exercise improves blood glucose control, lowers cardiovascular risk factors, aids in weight loss and improves overall wellbeing (Gilbert and Krum, 2015). The present study investigated the modulatory role and antioxidant potential of aerobic exercise in diabetes-induced myocardial injury.

Bioinformatics analysis was used to identify potential DEGs (She et al., 2025). The top hub genes were identified using four different algorithms. An upshot diagram of the results of these algorithms revealed nine common hub genes: FGG, HGD, PROC, TRADD, GC, CCNA1, SPAG5, CASP8 and TOP2A. GO and KEGG enrichment analyses were used to investigate the functions of the upregulated OS-DCM-trained DEG hub genes. The most enriched GO categories included “extrinsic apoptotic signaling pathway via death domain receptors,” “extrinsic apoptotic signaling pathway” and “cysteine-type endopeptidase activity involved in apoptotic signaling pathway.” Hub genes were mainly involved in apoptotic processes, such as “IL-17 signaling pathway,” “TNF signaling pathway,” “apoptosis” and “necroptosis” in the KEGG enrichment analysis. Some genes involved in DCM that are differentially expressed in response to OS have been studied previously. American Diabetes Association (2012) demonstrated that the activated nuclear catenin/c-Myc axis is responsible for oxidative cardiac impairment. In addition, Liu et al. (2017) discovered that excessive ROS production in DCM can activate the TLR-4/MyD-88/CASP8/CASP3 signaling pathway, leading to cardiomyocyte apoptosis. Subsequently, it was confirmed that aerobic exercise improved the expression of central DCM genes in rats.

In the present study, 8 weeks of treadmill exercise reduced blood glucose levels in diabetic rats; however, the improvement observed was not statistically significant compared with the DCM group. This suggested that 8 weeks of aerobic exercise can partially mitigate diabetes-induced hyperglycemia. In patients with type 2 diabetes, increased blood glucose is mainly associated with reduced sensitivity to insulin (Liu et al., 2015; Su et al., 2023). In patients with diabetes, insufficient insulin sensitivity leads to persistently elevated blood glucose levels. Aerobic exercise enhances insulin sensitivity and facilitates the translocation of glucose transporter 4 to the cell membrane, promoting glucose uptake into cells, thereby lowering blood glucose levels (Galicia-Garcia et al., 2020). Way et al. (2016) also showed that the weight of diabetic rats in a D2M group was markedly decreased, along with a notable increase in FBG levels.

Cardiac function and myocardial enzyme levels were assessed in each group. Compared with those in the control group, the DCM group exhibited significantly elevated cardiac function and myocardial enzyme levels, indicating heart damage. These indicators significantly improved in the DCME group. Similarly, both H&E and Masson’s trichrome staining showed that aerobic exercise improved the myocardium of the DCM rats. Wang et al. (2019) a used a HFD and STZ to induce DCM, and disrupted myocardial alignment and interstitial fibrosis were observed. In addition, Wu S. et al. (2022) demonstrated the presence of myocardial fibrosis in a rat model of DCM using Masson’s trichrome staining and Sirius red staining techniques. These previous findings indicated that STZ and HFD effectively replicate DCM in a rat model, and that aerobic exercise may improve cardiac function and enzyme levels in rats with DCM.

OS is associated with the occurrence and progression of pathological structural and functional changes in DCM (Ren et al., 2020; Faria and Persaud, 2017). Under DCM conditions, antioxidant factors such as SOD and GSH are markedly reduced in the heart tissue, whereas reactive MDA generation, which is responsible for cellular OS, is notably increased (Liao et al., 2017; Wilson et al., 2018). Thus, therapeutic molecules and methods that target intracellular OS represent potential DCM treatment strategies. The present study found that aerobic exercise reduced MDA levels in rat myocardial tissues, increased SOD and GSH levels, and thus conferred antioxidant stress resistance. Kowluru and Mishra (2015) reported that aerobic and resistance exercises may improve functional capacity and maximum load-carrying capacity, respectively. Furthermore, Gomes et al. (2020) reported that aerobic exercise can mitigate OS and cell death in mitochondria through the modulation of the Nrf2/glycogen synthase kinase 3β signaling pathway, thus improving cognitive impairment observed in an aging model induced by D-galactose.

The predicted hub genes of the present study were tested and only the mRNA and protein expression levels of PROC were revealed to match the trend predicted by bioinformatics analysis. Aerobic exercise may exert a cardioprotective effect by regulating PROC to improve DCM. APC, a serine protease belonging to the trypsin family, is produced during the initial phase of blood coagulation through limited proteolysis of PROC by thrombin, which binds to endothelial thrombomodulin (Xie et al., 2024; Esmon and Owen, 1984). APC is a multifunctional enzyme that serves an important role in the regulation of blood coagulation, inflammation and apoptosis. It exhibits anti-inflammatory and cytoprotective properties that contribute to its diverse physiological effects (Leon et al., 2022; Biswas et al., 2024). In the present study, compared with in the control group, the APC content in the DCM group was significantly decreased, whereas the APC content in the DCME group was significantly higher than that in the DCM group, indicating that aerobic exercise significantly increased the levels of APC, thus serving a role in alleviating DCM.

Previous studies have shown that APC induces the expression of protective genes in endothelial cells by activating endothelial protein C receptor (O'Brien et al., 2006) or the receptor cascade PAR1 (Esmon, 2006). Previous studies have shown that the PAR1 and PAR3 subtype receptors serve a role in neuroprotection, particularly in response to NMDA- and staurosporin-induced neuronal apoptosis (Guo et al., 2004). Liu et al. (2012) demonstrated that PAR1 can activate the Nrf2/HO-1 signaling pathway, thereby exerting antioxidant stress resistance. In addition, Peng H. et al. (2022) found that GF1 may reduce triptolide cytotoxicity in HL-7702 cells by activating the kelch-like ECH-associated protein 1 (Keap1)/Nrf2/antioxidant response element antioxidant pathway. In the present study, the results showed that compared with those in the control group, the protein levels of Nrf2 and HO-1 were significantly reduced in the DCM group, whereas PAR1 protein levels showed no significant alteration; by contrast, the protein levels of PAR1, Nrf2 and HO-1 were significantly increased in the DCME group compared with those in the DCM group.

According to this study, moderate-intensity aerobic exercise has clear guiding significance for the clinical exercise management of patients with DCM. It can inhibit OS by activating the PROC/PAR1/Nrf2/HO-1 pathway, thereby improving DCM. Clinically, the intensity parameters of this exercise are as follows: choose low-to-moderate impact exercises such as brisk walking and jogging, 3-5 times a week, 30–45 min each time, with heart rate maintained at 60%–70% of “220 minus age” (Magutah et al., 2022). This protocol is easy to implement, highly safe, and can help improve DCM. In conclusion, aerobic exercise may alleviate DCM through the aforementioned pathway; the study results lay a foundation for exploring how exercise regulates OS and affects DCM progression, and also provide new perspectives for disease diagnosis and prognosis.

However, the present study had certain limitations. Firstly, the GEO database was used to analyze the key genes involved in aerobic exercise-induced DCM improvement. Notably, the present study used a mixed dataset of rats (GSE4745, GSE6880, GSE5606) and mice (GSE4616) to analyze DEGs. Integrating data from these two species is an effective approach in bioinformatics and systems biology, especially when studying conserved biological mechanisms. This is because rats and mice have notable genetic and physiological similarities, which makes cross-species analysis valuable for improving the robustness and universality of research results. When integrating rat and mouse diabetic cardiomyopathy (DCM) data, the core potential limitation of this study is that the inherent differences in DCM pathophysiological traits between the two species cannot be fully eliminated, which may compromise the accuracy of gene expression analysis. To address this, targeted strategies were adopted during data processing, including only genes significantly differentially expressed (|log2FC|>1, P < 0.05) in both species to exclude interference from species-specific genes, prioritizing genes with consistent expression trends, and focusing on core, functionally conserved pathways (e.g., Nrf2/HO-1, PROC/PAR1 pathways) shared by the two species to improve conclusion reliability (Cheng et al., 2024; Sun et al., 2021). Future studies could further optimize the design by using a single species with an increased sample size or adopting advanced bioinformatics techniques to minimize inter-species differences and reduce potential biases (Li et al., 2024; Deng et al., 2024).

5 Conclusion

Diabetic cardiomyopathy (DCM) is closely linked to oxidative stress (OS). This study combined bioinformatics and animal experiments to confirm that 8 weeks of moderate-intensity aerobic exercise alleviates DCM in rats. Bioinformatics identified nine hub genes, with protein C (PROC) as the key target. Exercise upregulated PROC, activated the PROC/PAR1/Nrf2/HO-1 pathway, improved cardiac function, reduced myocardial injury markers and enhanced antioxidant capacity (Figure 10). Limitations include cross-species data integration. These findings highlight PROC as a novel target and aerobic exercise as a safe DCM intervention, providing insights for clinical management.

Figure 10
Flowchart depicting two processes. On the left: bioinformatics analysis leads to animal experiments and results. On the right: aerobic exercise influences PROC, PAR1, and Nrf2/HO-1, resulting in a reduction of oxidative stress (OS) and diabetic cardiomyopathy (DCM) injury.

Figure 10. Schematic diagram of aerobic exercise alleviating oxidative stress and diabetic cardiomyopathy (DCM) via the PROC/PAR1/Nrf2/HO-1 signalling pathway. Aerobic exercise alleviates DCM by targeting the hub gene PROC, as identified through bioinformatics and animal models. Mechanistically, aerobic exercise upregulates PROC expression and activates the PROC/PAR1/Nrf2/HO-1 axis, leading to enhanced antioxidant capacity, reduced myocardial injury, and improved cardiac function. PROC, protein C; PAR1, proteinase-activated receptor 1; Nrf2, nuclear factor (erythroid-derived 2)-like 2; HO-1, heme oxygenase-1; DCM, diabetic cardiomyopathy.

Data availability statement

The data generated in the present study may be requested from the corresponding authors.

Ethics statement

The animal study was approved by Institutional Animal Care and Use Committee of Nanjing University of Chinese Medicine. The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

SX: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – original draft, Writing – review and editing. CC: Conceptualization, Data curation, Formal Analysis, Methodology, Project administration, Supervision, Validation, Writing – original draft. TT: Conceptualization, Data curation, Formal Analysis, Project administration, Validation, Writing – review and editing. ZZ: Conceptualization, Data curation, Investigation, Methodology, Software, Supervision, Writing – original draft. CY: Conceptualization, Investigation, Software, Writing – original draft, Project administration, Resources, Visualization. YC: Conceptualization, Project administration, Writing – original draft, Formal Analysis, Methodology. JL: Conceptualization, Formal Analysis, Writing – original draft, Investigation, Software. JX: Conceptualization, Writing – original draft, Data curation, Methodology, Supervision. LW: Conceptualization, Data curation, Funding acquisition, Resources, Visualization, Writing – original draft, Writing – review and editing. YZ: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing.

Funding

The author(s) declared that financial support was received for this work and/or its publication. The present project was supported by the National Natural Science Foundation of China (grant no. 82302847) and the Jiangsu Province Basic Research Program (grant no. BK20241907).

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphys.2026.1727186/full#supplementary-material

References

American Diabetes Association (2012). Standards of medical care in diabetes--2012. Diabetes Care 1, S11–S63. doi:10.2337/dc12-s011

PubMed Abstract | CrossRef Full Text | Google Scholar

Biswas I., Giri H., Panicker S. R., Rezaie A. R. (2024). Thrombomodulin switches signaling and protease-activated receptor 1 cleavage specificity of thrombin. Arterioscler. Thromb. Vasc. Biol. 44, 603–616. doi:10.1161/ATVBAHA.123.320185

PubMed Abstract | CrossRef Full Text | Google Scholar

Cheng X., Tan Y., Li H., Huang J., Zhao D., Zhang Z., et al. (2022). Fecal 16S rRNA sequencing and multi-compartment metabolomics revealed gut microbiota and metabolites interactions in APP/PS1 mice. Comput. Biol. Med. 151, 106312. doi:10.1016/j.compbiomed.2022.106312

PubMed Abstract | CrossRef Full Text | Google Scholar

Caturano A., Rocco M., Tagliaferri G., Piacevole A., Nilo D., Di Lorenzo G., et al. (2025). Oxidative stress and cardiovascular complications in type 2 diabetes: from pathophysiology to lifestyle modifications. Antioxidants (Basel) 14, 72. doi:10.3390/antiox14010072

PubMed Abstract | CrossRef Full Text | Google Scholar

Chavali V., Tyagi S. C., Mishra P. K. (2013). Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab. Syndr. Obes. 6, 151–160. doi:10.2147/DMSO.S30968

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen X., Chen C., Tian X., He L., Zuo E., Liu P., et al. (2024). DBAN: an improved dual branch attention network combined with serum raman spectroscopy for diagnosis of diabetic kidney disease. Talanta 266, 125052. doi:10.1016/j.talanta.2023.125052

PubMed Abstract | CrossRef Full Text | Google Scholar

Cheng X., Huang J., Li H., Zhao D., Liu Z., Zhu L., et al. (2024). Quercetin: a promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis. Phytomedicine 126, 154887. doi:10.1016/j.phymed.2023.154887

PubMed Abstract | CrossRef Full Text | Google Scholar

Clifford P. S., Ferguson B. S., Jasperse J. L., Hill M. A. (2018). Arteriolar vasodilation involves actin depolymerization. Am. J. physiol. Heart Circ. Physiol. 315, H423–H428. doi:10.1152/ajpheart.00723.2017

PubMed Abstract | CrossRef Full Text | Google Scholar

Cui H., Hu D., Xu J., Zhao S., Song Y., Qin G., et al. (2024). Identification of hub genes associated with diabetic cardiomyopathy using integrated bioinformatics analysis. Sci. Reports 14 (1), 15324. doi:10.1038/s41598-024-65773-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Deng J., Liu Q., Ye L., Wang S., Song Z., Zhu M., et al. (2024). The janus face of mitophagy in myocardial ischemia/reperfusion injury and recovery. Biomed. Pharmacother. 173, 116337. doi:10.1016/j.biopha.2024.116337

PubMed Abstract | CrossRef Full Text | Google Scholar

Dias K. A., Link M. S., Levine B. D. (2018). Exercise training for patients with hypertrophic cardiomyopathy: JACC review topic of the week. J. Am. Coll. Cardiol. 72, 1157–1165. doi:10.1016/j.jacc.2018.06.054

PubMed Abstract | CrossRef Full Text | Google Scholar

Esmon C. T. (2006). Inflammation and the activated protein C anticoagulant pathway. Semin. Thromb. Hemost. 1, 49–60. doi:10.1055/s-2006-939554

PubMed Abstract | CrossRef Full Text | Google Scholar

Esmon C. T., Owen W. G. (1984). Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc. Natl. Acad. Sci. 78, 2249–2252. doi:10.1073/pnas.78.4.2249

PubMed Abstract | CrossRef Full Text | Google Scholar

Faria A., Persaud S. J. (2017). Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential. Pharmacol. Ther. 172, 50–62. doi:10.1016/j.pharmthera.2016.11.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Galicia-Garcia U., Benito-Vicente A., Jebari S., Larrea-Sebal A., Siddiqi H., Uribe K. B., et al. (2020). Martín: pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 21. doi:10.3390/ijms21176275

PubMed Abstract | CrossRef Full Text | Google Scholar

Gerber L. K., Aronow B. J., Matlib M. A. (2006). Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat hearts. Am. J. Physiol. Cell Physiol. 291, C1198–C1207. doi:10.1152/ajpcell.00246.2006

PubMed Abstract | CrossRef Full Text | Google Scholar

Gilbert R. E., Krum H. (2015). Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet 385, 2107–2117. doi:10.1016/S0140-6736(14)61402-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Glyn-Jones S., Song S., Black M. A., Phillips A. R. J., Choong S. Y., Cooper G. J. S. (2007). Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial disease. Physiol. Genomics 28, 284–293. doi:10.1152/physiolgenomics.00204.2006

PubMed Abstract | CrossRef Full Text | Google Scholar

Gomes M. J., Pagan L. U., Lima A. R. R., Reyes D. R. A., Martinez P. F., Damatto F. C., et al. (2020). Effects of aerobic and resistance exercise on cardiac remodelling and skeletal muscle oxidative stress of infarcted rats. J. Cell Mol. Med. 24, 5352–5362. doi:10.1111/jcmm.15191

PubMed Abstract | CrossRef Full Text | Google Scholar

Grabowski K., Riemenschneider M., Schulte L., Witten A., Schulz A., Stoll M., et al. (2015). Fetal-adult cardiac transcriptome analysis in rats with contrasting left ventricular mass reveals new candidates for cardiac hypertrophy. PLoS One 10, e0116807. doi:10.1371/journal.pone.0116807

PubMed Abstract | CrossRef Full Text | Google Scholar

Gu Z., Eils R., Schlesner M. (2016). Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849. doi:10.1093/bioinformatics/btw313

PubMed Abstract | CrossRef Full Text | Google Scholar

Guo H., Liu D., Gelbard H., Cheng T., Insalaco R., Fernández J. A., et al. (2004). Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron 41, 563–572. doi:10.1016/j.neuron.2023.12.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Guo Q., Zhu Q., Zhang T., Qu Q., Cheang I., Liao S., et al. (2022). Integrated bioinformatic analysis reveals immune molecular markers and potential drugs for diabetic cardiomyopathy. Front. Endocrinology 13, 933635. doi:10.3389/fendo.2022.933635

PubMed Abstract | CrossRef Full Text | Google Scholar

Hu J., Pang W., Chen J., Bai S., Zheng Z., Wu X. (2013). Hypoglycemic effect of polysaccharides with different molecular weight of Pseudostellaria heterophylla. BMC Complement. Altern. Med. 13, 267. doi:10.1186/1472-6882-13-267

PubMed Abstract | CrossRef Full Text | Google Scholar

Huynh K., Bernardo B. C., McMullen J. R., Ritchie R. H. (2014). Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol. Ther. 142, 375–415. doi:10.1016/j.pharmthera.2014.01.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Kowluru R. A., Mishra M. (2015). Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim. Biophys. Acta 11, 2474–2483. doi:10.1016/j.bbadis.2015.08.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Lehti T. M., Silvennoinen M., Kivelä R., Kainulainen H., Komulainen J. (2007). Effects of streptozotocin-induced diabetes and physical training on gene expression of titin-based stretch-sensing complexes in mouse striated muscle. Am. J. Physiol. Endocrinol. Metab. 292, E533–E542. doi:10.1152/ajpendo.00229.2006

PubMed Abstract | CrossRef Full Text | Google Scholar

Leon G., Rehill A. M., Preston R. J. S. (2022). The protein C pathways. Curr. Opin. Hematol. 29, 251–258. doi:10.1097/MOH.0000000000000726

PubMed Abstract | CrossRef Full Text | Google Scholar

Li X., Meng C., Han F., Yang J., Wang J., Zhu Y., et al. (2021). Vildagliptin attenuates myocardial dysfunction and restores autophagy via miR-21/SPRY1/ERK in diabetic mice heart. Front. Pharmacol. 12, 634365. doi:10.3389/fphar.2021.634365

PubMed Abstract | CrossRef Full Text | Google Scholar

Li W., Liu X., Liu Z., Xing Q., Liu R., Wu Q., et al. (2024). The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review. Front. Pharmacol. 15, 1416403. doi:10.3389/fphar.2024.1416403

PubMed Abstract | CrossRef Full Text | Google Scholar

Li K., Li S., Jia H., Song Y., Chen Z., Wang Y. (2025). Aerobic exercise alleviates cardiac dysfunction correlated with lipidomics and mitochondrial quality control. Antioxidants (Basel) 14, 748. doi:10.3390/antiox14060748

PubMed Abstract | CrossRef Full Text | Google Scholar

Liao H., Zhu J., Feng H., Ni J., Zhang N., Chen S., et al. (2017). Myricetin possesses potential protective effects on diabetic cardiomyopathy through inhibiting IκBα/NFκB and enhancing Nrf2/HO-1. Oxid. Med. Cell Longev. 2017, 8370593. doi:10.1155/2017/8370593

PubMed Abstract | CrossRef Full Text | Google Scholar

Libonati J. R., Sabri A., Xiao C., Macdonnell S. M., Renna B. F. (1985). Exercise training improves systolic function in hypertensive myocardium. J. Appl. Physiol. 111, 1637–1643. doi:10.1152/japplphysiol.00292.2011

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu J., Hou S., Tsai C., Huang C. Y., Yang W. H., Tang C. H. (2012). Thrombin induces heme oxygenase-1 expression in human synovial fibroblasts through protease-activated receptor signaling pathways. Arthritis Research and Therapy 14, R91. doi:10.1186/ar3815

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu Z., Wang J., Qiu C., Guan G. c., Liu X. h., Li S. j., et al. (2015). Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway. Acta Pharmacol. Sin. 36, 323–333. doi:10.1038/aps.2014.127

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu P., Su J., Song X., Wang S. (2017). Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy. Biochem. Biophys. Res. Commun. 493, 1573–1580. doi:10.1016/j.bbrc.2017.10.027

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu T., Li X., Cui Y., Meng P., Zeng G., Wang Y., et al. (2021). Bioinformatics analysis identifies potential ferroptosis key genes in the pathogenesis of intracerebral hemorrhage. Front. Neurosci. 15, 661663. doi:10.3389/fnins.2021.661663

PubMed Abstract | CrossRef Full Text | Google Scholar

Livak K. J., Schmittgen T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif.) 25, 402–408. doi:10.1006/meth.2001.1262

PubMed Abstract | CrossRef Full Text | Google Scholar

Ma X., Gao H., Wang Z., Zhu D., Dai W., Wu M., et al. (2025). Beneficial effects of different types of exercise on diabetic cardiomyopathy. Biomolecules 15, 1223. doi:10.3390/biom15091223

PubMed Abstract | CrossRef Full Text | Google Scholar

Magutah K., Mbuthia G., Akiruga J. A., Haile D., Thairu K. (2022). Effect of fixed 7.5 minutes' moderate intensity exercise bouts on body composition and blood pressure among sedentary adults with prehypertension in Western-Kenya. PLOS Glob. Public Health 2, e0000806. doi:10.1371/journal.pgph.0000806

PubMed Abstract | CrossRef Full Text | Google Scholar

Mohammed Yusof N. L., Zainalabidin S., Mohd Fauzi N., Budin S. B. (2018). Hibiscus sabdariffa (roselle) polyphenol-rich extract averts cardiac functional and structural abnormalities in type 1 diabetic rats. Appl. Physiol. Nutr. Metab. 43, 1224–1232. doi:10.1139/apnm-2018-0084

PubMed Abstract | CrossRef Full Text | Google Scholar

Mullarkey C. J., Edelstein D., Brownlee M. (1990). Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173, 932–939. doi:10.1016/s0006-291x(05)80875-7

PubMed Abstract | CrossRef Full Text | Google Scholar

O'Brien L. A., Gupta A., Grinnell B. W. (2006). Activated protein C and sepsis. Front. Biosci. 11, 676–698. doi:10.2741/1827

PubMed Abstract | CrossRef Full Text | Google Scholar

Palomer X., Pizarro-Delgado J., Vázquez-Carrera M. (2018). Emerging actors in diabetic cardiomyopathy: heartbreaker biomarkers or therapeutic targets? Trends Pharmacol. Sci. 39, 452–467. doi:10.1016/j.tips.2018.02.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Pei W., Zhang Y., Zhu X., Zhao C., Li X., Lü H., et al. (2024). Multitargeted immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles. ACS Nano 18, 2782–2799. doi:10.1021/acsnano.3c05847

PubMed Abstract | CrossRef Full Text | Google Scholar

Penckofer S., Schwertz D., Florczak K. (2002). Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J. Cardiovasc. Nurs. 16, 68–85. doi:10.1097/00005082-200201000-00007

PubMed Abstract | CrossRef Full Text | Google Scholar

Peng M. L., Fu Y., Wu C. W., Zhang Y., Ren H., Zhou S. S. (2022a). Signaling pathways related to oxidative stress in diabetic cardiomyopathy. Front. Endocrinology 13, 907757. doi:10.3389/fendo.2022.907757

PubMed Abstract | CrossRef Full Text | Google Scholar

Peng H., You L., Yang C., Wang K., Liu M., Yin D., et al. (2022b). Ginsenoside Rb1 attenuates triptolide-induced cytotoxicity in HL-7702 cells via the activation of Keap1/Nrf2/ARE pathway. Front. Pharmacol. 12, 723784. doi:10.3389/fphar.2021.723784

PubMed Abstract | CrossRef Full Text | Google Scholar

Qi S., Li X., Yu J., Yin L. (2024). Research advances in the application of metabolomics in exercise science. Front. Physiol. 14, 1332104. doi:10.3389/fphys.2023.1332104

PubMed Abstract | CrossRef Full Text | Google Scholar

Ren B., Zhang Y., Liu S., Cheng X. J., Yang X., Cui X. G., et al. (2020). Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways. J. Cell. Mol. Med. 24, 12355–12367. doi:10.1111/jcmm.15725

PubMed Abstract | CrossRef Full Text | Google Scholar

Sano T., Umeda F., Hashimoto T., Nawata H., Utsumi H. (1998). Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia 41, 1355–1360. doi:10.1007/s001250051076

PubMed Abstract | CrossRef Full Text | Google Scholar

She H., Zheng J., Zhao G., Du Y., Tan L., Chen Z. S., et al. (2025). Arginase 1 drives mitochondrial cristae remodeling and PANoptosis in ischemia/hypoxia-induced vascular dysfunction. Signal Transduct. Target Ther. 10, 167. doi:10.1038/s41392-025-02255-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Su M., Tang T., Tang W., Long Y., Wang L., Liu M. (2023). Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review. Front. Immunol. 14, 1243834. doi:10.3389/fimmu.2023.1243834

PubMed Abstract | CrossRef Full Text | Google Scholar

Sun T. L., Li W. Q., Tong X. L., Liu X. Y., Zhou W. H. (2021). Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway. Eur. J. Pharmacol. 891, 173690. doi:10.1016/j.ejphar.2020.173690

PubMed Abstract | CrossRef Full Text | Google Scholar

Tribouilloy C., Rusinaru D., Mahjoub H., Tartière J. M., Kesri-Tartière L., Godard S., et al. (2008). Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study. Heart 94, 1450–1455. doi:10.1136/hrt.2007.128769

PubMed Abstract | CrossRef Full Text | Google Scholar

Van Lunteren E., Moyer M. (2007). Oxidoreductase, morphogenesis, extracellular matrix, and calcium ion-binding gene expression in streptozotocin-induced diabetic rat heart. Am. J. Physiol. Endocrinol. Metab. 293, E759–E768. doi:10.1152/ajpendo.00191.2007

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang C., Feng X. (2019). Exercise protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway in rats. J. Cell Physiol. 234, 1682–1688. doi:10.1002/jcp.27038

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang S. Q., Li D., Yuan Y. (2019). Long-term moderate intensity exercise alleviates myocardial fibrosis in type 2 diabetic rats via inhibitions of oxidative stress and TGF-β1/Smad pathway. J. Physiol. Sci. 69, 861–873. doi:10.1007/s12576-019-00696-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Watanabe K., Thandavarayan R. A., Harima M., Sari F. R., Gurusamy N., Veeraveedu P. T., et al. (2010). Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy. Curr. Cardiol. Rev. 6, 280–290. doi:10.2174/157340310793566145

PubMed Abstract | CrossRef Full Text | Google Scholar

Way K. L., Hackett D. A., Baker M. K., Johnson N. A. (2016). The effect of regular exercise on insulin sensitivity in type 2 diabetes. Diabetes Metab. J. 40, 253–271. doi:10.4093/dmj.2016.40.4.253

PubMed Abstract | CrossRef Full Text | Google Scholar

Williamson J. R., Chang K., Frangos M., Hasan K. S., Ido Y., Kawamura T., et al. (1993). Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801–813. doi:10.2337/diab.42.6.801

PubMed Abstract | CrossRef Full Text | Google Scholar

Wilson A. J., Gill E. K., Abudalo R. A., Edgar K. S., Watson C. J., Grieve D. J. (2018). Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting. Heart 104, 293–299. doi:10.1136/heartjnl-2017-311448

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu X., Zhou X., Lai S., Liu J., Qi J. (2022a). Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo. FASEB Journal Official Publication Fed. Am. Soc. Exp. Biol. 36 (9), e22505. doi:10.1096/fj.202200543RRR

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu S., Zhu J., Wu G., Ying P., Bao Z., Ding Z., et al. (2022b). 6-Gingerol alleviates ferroptosis and inflammation of diabetic cardiomyopathy via the Nrf2/HO-1 pathway. Oxid. Med. Cell. Longev. 2022, 3027514. doi:10.1155/2022/3027514

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu Q., Zhao D., Leng Y., Chen C., Xiao K., Wu Z., et al. (2024). Identification of the hypoglycemic active components of Lonicera japonica thunb. and Lonicera hypoglauca Miq. by UPLC-Q-TOF-MS. Molecules 29, 4848. doi:10.3390/molecules29204848

PubMed Abstract | CrossRef Full Text | Google Scholar

Xie G., Xu Z., Li F., Kong M., Wang P., Shao Y. (2024). Aerobic exercise ameliorates cognitive disorder and declined oxidative stress via modulating the Nrf2 signaling pathway in D-galactose induced aging mouse model. Neurochem. Res. 49, 2408–2422. doi:10.1007/s11064-024-04164-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Xu M., Zhou H., Hu P., Pan Y., Wang S., Liu L., et al. (2023). Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning. Front. Immunol. 14, 1084531. doi:10.3389/fimmu.2023.1084531

PubMed Abstract | CrossRef Full Text | Google Scholar

Yan X., Eynon N., Papadimitriou I. D., Kuang J., Munson F., Tirosh O., et al. (2017). The gene SMART study: method, study design, and preliminary findings. BMC Genomics 18, 821. doi:10.1186/s12864-017-4186-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Yang L., Lin W., Yan X., Zhang Z. (2024). Comparative effects of lifelong moderate-intensity continuous training and high-intensity interval training on blood lipid levels and mental well-being in naturally ageing mice. Exp. Gerontol. 194, 112519. doi:10.1016/j.exger.2024.112519

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang Y., Gago-Lopez N., Li N., Zhang Z., Alver N., Liu Y., et al. (2019a). MacLellan: single-cell imaging and transcriptomic analyses of endogenous cardiomyocyte dedifferentiation and cycling. Cell Discovery 5, 30. doi:10.1038/s41421-019-0095-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang Y., Zhang L., Fan X., Yang W., Yu B., Kou J., et al. (2019b). Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways. Biomed. Pharmacother. 113, 108780. doi:10.1016/j.biopha.2019.108780

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang Y., Zhu L., Li X., Ge C., Pei W., Zhang M., et al. (2024). M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2/HIF-1α axis mediated metabolic reprogramming of macrophages. Redox Biol. 69, 103016. doi:10.1016/j.redox.2023.103016

PubMed Abstract | CrossRef Full Text | Google Scholar

Glossary

BNP brain natriuretic peptide

BP biological process

c-TnT cardiac troponin T

CC cellular component

CK-MB creatine kinase MB

DCM diabetic cardiomyopathy

DCME DCM plus exercise

DEGs differentially expressed genes

ELISA enzyme-linked immunosorbent assay

FBG fasting blood glucose

FINS fasting plasma insulin

GEO Gene Expression Omnibus

GO Gene Ontology

GSH glutathione

HFD high-fat diet

HO-1 heme oxygenase-1

HOMA-IR homeostatic model assessment of insulin resistance

ISI insulin sensitivity index

KEGG Kyoto Encyclopedia of Genes and Genomes

LDH lactate dehydrogenase

logFC log2 fold change

LVEF left ventricular ejection fraction

LVFS left ventricular fractional shortening

LVIDd left ventricular internal diastolic dimension

LVIDs left ventricular internal dimension systole

MDA malondialdehyde

MF molecular function

Nrf2 nuclear factor (erythroid-derived 2)-like 2

OS oxidative stress

PCA principal component analysis

PPI protein-protein interaction

PROC protein C

ROS reactive oxygen species

SOD superoxide dismutase

STRING Search Tool for the Retrieval of Interacting Genes

STZ streptozotocin

Keywords: aerobic exercise, bioinformatics, diabetes cardiomyopathy, oxidative stress, PROC/PAR1/Nrf2/HO-1 signaling pathway

Citation: Xie S, Chang C, Tran TM, Zhou Z, Yu C, Chen Y, Lin J, Xu J, Wang L and Zhang Y (2026) Aerobic exercise inhibits oxidative stress and improves diabetic cardiomyopathy in rats by activating the PROC/PAR1/Nrf2/HO-1 signaling pathway. Front. Physiol. 17:1727186. doi: 10.3389/fphys.2026.1727186

Received: 17 October 2025; Accepted: 12 January 2026;
Published: 29 January 2026.

Edited by:

Haibo Wang, Anhui Science and Technology University, China

Reviewed by:

Jianli Jimmy Zhao, University of Alabama at Birmingham, United States
Ahsan Riaz Khan, Tongji University, China
Iqbal Ali Shah, China Medical University, Taiwan

Copyright © 2026 Xie, Chang, Tran, Zhou, Yu, Chen, Lin, Xu, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lei Wang, d2FuZ2xlaUBuanVjbS5lZHUuY24=; Yang Zhang, eWFuZ3poYW5nQG5qdWNtLmVkdS5jbg==

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.